These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26605515)

  • 1. Complement component 3: a new paradigm in tuberculosis vaccine.
    De La Fuente J; Gortázar C; Juste R
    Expert Rev Vaccines; 2016; 15(3):275-7. PubMed ID: 26605515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vaccination with heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculosis.
    Beltrán-Beck B; de la Fuente J; Garrido JM; Aranaz A; Sevilla I; Villar M; Boadella M; Galindo RC; Pérez de la Lastra JM; Moreno-Cid JA; Fernández de Mera IG; Alberdi P; Santos G; Ballesteros C; Lyashchenko KP; Minguijón E; Romero B; de Juan L; Domínguez L; Juste R; Gortazar C
    PLoS One; 2014; 9(5):e98048. PubMed ID: 24842853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
    Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
    Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M; Kita Y
    Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK; Khuller GK
    Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
    Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of mycobacteriosis in zebrafish (Danio rerio) mucosally vaccinated with heat-inactivated Mycobacterium bovis.
    Risalde MA; López V; Contreras M; Mateos-Hernández L; Gortázar C; de la Fuente J
    Vaccine; 2018 Jul; 36(30):4447-4453. PubMed ID: 29935860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches to tuberculosis prevention: DNA vaccines.
    Rivas-Santiago B; Cervantes-Villagrana AR
    Scand J Infect Dis; 2014 Mar; 46(3):161-8. PubMed ID: 24450840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in tuberculosis vaccine strategies.
    Skeiky YA; Sadoff JC
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis.
    Jeon BY; Kim SC; Eum SY; Cho SN
    Microbes Infect; 2011 Mar; 13(3):284-90. PubMed ID: 21093603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.
    Chu JS; Villarreal DO; Weiner DB
    Methods Mol Biol; 2016; 1403():355-61. PubMed ID: 27076140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?
    Smaill F; Xing Z
    Expert Rev Vaccines; 2014 Aug; 13(8):927-30. PubMed ID: 24935214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
    Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.